The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 157: ASCO GU 2022 Sasatuzimab and pembrolizumab in bladder cancer
17 minutes
Posted Feb 18, 2022 at 10:16 pm.
0:00
17:16
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Petros Grivas describes the results of this phase 2 trial.
Previous
Episode 154: ASCO GU 2022 MAGNITUDE trial of niraparib and abiraterone in metastatic CRPC
Next
Episode 156: ASCO GU 2022 1st line olaparib and durvalumab in bladder cancer
← See all 501 episodes of The Uromigos